Latest guidance  

COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
COVID-19 rapid guideline: managing COVID-19
Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain
RenalSense Clarity RMS for acute kidney injury

Latest guidance in consultation  

Weight Management
Nivolumab with ipilimumab and chemotherapy for untreated advanced non-small-cell lung cancer [ID1566]
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea [ID1499]
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for moderate rheumatoid arthritis after conventional DMARDs have failed (partial review of TA375) [ID2710]
Magnetic resonance therapy for knee osteoarthritis

Explore NICE

  1. News|
  2. About|
  3. Events|
  4. Get involved

Latest news  

  1. NICE recommends range of effective treatments for people with chronic primary pain and calls on healthcare professionals to recognise and treat a person’s pain as valid and unique to them
  2. NICE publishes single guideline for managing COVID-19
  3. Triple therapy recommended by NICE for patients with multiple myeloma
  4. Unpaid carers should be offered advice and support, says NICE

Tweets

by @NICEcomms